Skip to NavigationSkip to content


Global Cardiology Summit

NHS looks to ESC for next-gen heart drug data

ESC congress sign
Pharma companies will present data on several new heart drugs at the ESC 2015 congress

New data is expected to be presented at the European Cardiology Society congress in London, on the high cholesterol drugs that are set to battle for market access in the UK.

Amgen’s Repatha (evolocumab) was the first in this new class of drugs - called PCSK9 inhibitors - to be approved, when it was signed off by the European Commission in July and has been approved by the FDA today.

Westminster Health Forum Keynote Seminar - Cardiovascular Diseases: commissioning, innovation, patient experience and outcomes

Cardiovascular Medicine: An Overview

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches